Comparison of high dose rate, low dose rate, and high dose rate fractionated radiation for optimizing differences in radiosensitivities in vitro

Radiation Oncology Investigations

Volumn 6, Issue 5, 1998, Pages 209-215

  Wilkins, Ruth C ^a   Ng, C E ^b   Raaphorst, G P ^b  

^a HEALTH CANADA   (Canada)

^b OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

Fibroblasts; Fractionated radiation; Intrinsic radiosensitivity; Predictive assay

Indexed keywords

ARTICLE; CELL CYCLE; CELL LINE; CELL SURVIVAL; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PREDICTION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIOSENSITIVITY;

ADULT; CELL SURVIVAL; CELLS, CULTURED; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FIBROBLASTS; FLOW CYTOMETRY; HUMANS; MALE; MELANOMA; RADIATION TOLERANCE; RADIOTHERAPY DOSAGE; TUMOR CELLS, CULTURED;

EID: 0031767307     PISSN: 10657541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6823(1998)6:5<209::AID-ROI2>3.0.CO;2-G     Document Type: Article

References (27)

1. Nyman J, Burnet NG, Turesson I, Peacock JH: Correlation between in vitro radiosensitivity and normal tissue response. Part I - normal tissue response. Br J Cancer 66:6-6, 1992.
2. Bentzen SM, Overgaard M, Overgaard J: Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity. Eur J Cancer 29A:1373-1376, 1993.
3. Murnane JP, Kapp LN: A critical look at the association of human genetic syndromes with sensitivity to ionizing radiation. Semin Cancer Biol 4:93-104, 1993.
4. Taylor AMR, Harnden DG, Arlett CF, Harcourt SA, Lehmann AR, Stevens S, Bridges BA: Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature 258:427-429, 1975.
5. 0) T-lymphocytes, T-lymphocyte lines, lymphoblastoid cell lines and fibroblasts from normal donors, from ataxia-telangiectasia patients and from ataxia-telangiectasia heterozygotes. Int J Radiat Biol 54:929-943, 1988.
6. Turesson I: Individual variation and dose dependency in the progression rate of skin telangiectasia. Int J Radiat Oncol Biol Phys 19:1569-1574, 1990.
7. Little JB, Nove J, Strong LC, Nichols WW: Survival of human diploid skin fibroblasts from normal individuals after X- irradiation. Int J Radiat Biol 54:899-910, 1988.
8. Geara FB, Peters LJ, Ang KK, Wike JL, Sivon SS, Guttenberger R, Callender DL, Malaise EP, Brock WA: Intrinsic radiosensitivity of normal human fibroblasts and lymphocytes after high- and low-dose-rate irradiation. Cancer Res 52:6348-6352, 1992.
9. Geara FB, Peters LJ, Ang KK, Wike JL, Brock WA: Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys 27:1173-1179, 1993.
10. Burnet NG, Nyman J, Turesson I, Wurm R, Yarnold JR, Peacock JH: Prediction of normal-tissue tolerance to radiotherapy from in vitro cellular radiation sensitivity. Lancet 339:1570-1571, 1992.
11. Loeffler JS, Harris JR, Dahlberg WK, Little JB: In vitro radiosensitivity of human diploid fibroblasts derived from women with unusually sensitive clinical responses to definitive radiation therapy for breast cancer. Radiat Res 121:227-231, 1990.
12. Johansen J, Bentzen SM, Overgaard J, Overgaard M: Evidence for a positive correlation between in vitro radiosensitivity of normal human skin fibroblasts and the occurrence of subcutaneous fibrosis after radiotherapy. Int J Radiat Biol 66:407-412, 1994.
13. Raaphorst GP: Prediction of radiotherapy response using SF2: is it methodology or mythology? Radiother Oncol 28:187-188, 1993.
14. Brock WA, Tucker SL, Geara FB, Turesson I, Wike J, Nyman J, Peters LJ: Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer. Int J Radiat Oncol Biol Phys 32: 1371-1379, 1995.
15. Geara FB, Peters LJ, Ang KK, Wike JL, Brock WA: Radiosensitivity measurement of keratinocytes and fibroblasts from radiotherapy patients. Int J Radiat Oncol Biol Phys 24:287-293, 1992.
16. Begg AC, Russell NS, Knaken H, Lebesque JV: Lack of correlation of human fibroblast radiosensitivity in vitro with early skin reactions in patients undergoing radiotherapy. Int J Radiat Biol 64:393-405, 1993.
17. Bichay T, Feeley MM, Raaphorst GP: A comparison of heat sensitivity, radiosensitivity and PLDR in four human melanoma cell lines. Melanoma Research 2:63-69, 1992.
18. Brown RC, Raaphorst GP, Danjoux CE, Drouin P: Multi-organ fatal chronic complications following radiation treatment for cancer of the cervix - results of fibroblast assay. Gynecol Oncol 61:116-121, 1996.
19. Ng CE, Bussey AM, Raaphorst GP: Inhibition of potentially lethal and sublethal damage repair by camptothecin and etoposide in human melanoma cell lines. Int J Radiat Biol 66:49-57, 1994.
20. Brock WA, Baker FL, Wike JL, Sivon SL, Peters LJ: Cellular radiosensitivity of primary head and neck squamous cell carcinomas and local tumor control. Int J Radiat Oncol Biol Phys 18:1283-1286, 1990.
21. Brock WA, Baker FL, Peters LJ: Radiosensitivity of human head and neck squamous cell carcinomas in primary culture and its potential as a predictive assay of tumor radiocurability. Int J Radiat Biol 56:751-760, 1989.
22. West CM, Davidson SE, Burt PA, Hunter RD: The intrinsic radiosensitivity of cervical carcinoma: correlations with clinical data. Int J Radiat Oncol Biol Phys 31:841-846, 1995.
23. West CM, Davidson SE, Roberts SA, Hunter RD: Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix. Br J Cancer 68:819-823, 1993.
24. Weichselbaum RR, Beckett MA, Vijayakumar S, Simon MA, Awan AM, Nachman J, Panje WR, Goldman ME, Tybor AG, Moran WJ, et al.: Radiobiological characterization of head and neck and sarcoma cells derived from patients prior to radiotherapy. Int J Radiat Oncol Biol Phys 19:313-319, 1990.
25. Peters LJ, Brock WA: Cellular radiosensitivity as predictors of treatment outcome: where do we stand? Int J Radiat Oncol Biol Phys 25:147-148; 1993.
26. Peters LJ: The ESTRO Regaud lecture. Inherent radiosensitivity of tumor and normal tissue cells as a predictor of human tumor response. Radiother Oncol 17:177-190, 1990.
27. Lambin P, Fertil B, Malaise EP, Joiner MC: Multiphasic survival curves for cells of human tumor cell lines: induced repair or hypersensitive subpopulation? Radiat Res 138:S32-S36, 1994.